Global Healthcare Company Viatris Marks 60 Years of Manufacturing in Egypt

 Viatris Inc. (NASDAQ: VTRS), a global healthcare company, celebrated 60 years of manufacturing at its Cairo, Egypt site, reaffirming on this occasion its commitment to empowering people worldwide to live healthier at every stage of life.

Viatris is proud to mark the six decades of producing medicines in Egypt since the plant’s establishment in 1962. Viatris acquired the plant in 2020 after the company was formed by the combination of Mylan and Upjohn a legacy division of Pfizer, bringing together scientific, manufacturing and distribution expertise with proven regulatory, medical and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories.

Officials from the private and public sectors joined Viatris Egypt to celebrate this milestone, including H.E. Minister of Manpower Mr. Hassan Shehata, H.E Minister of Public Enterprises Sector Mr. Mahmoud Esmat, United States Chargé d’Affaires , a.i Ambassador Daniel Rubinstein, as well as representatives from the Ministry of Health and Population, the Egyptian Drug Authority, the Unified Procurement Authority , the World Health Organization, the American Chamber of Commerce Egypt, the Pharmaceutical Chamber, the Arab Hospitals Federation, and representatives from leading local healthcare institutions, associations and private and public entities.

Since the plant’s inception, Viatris’ manufacturing site has served millions of patients in Egypt with continuous operations over six decades; including the challenging COVID-19 pandemic period. The site employs around 300 employees and applies the highest global manufacturing standards with strict adherence to safety, quality, and compliance. The Viatris Egypt plant is part of our global manufacturing network of approximately 40 manufacturing facilities that produce complex dosage forms, injectables, oral solid doses and active pharmaceutical ingredients. In Egypt, Viatris produces treatments for a large array of diseases and conditions including, cardiovascular diseases, mental health, pain and more.

Suat Kumser, Head of Global Integrated Oral Solid Dosage and API manufacturing operations said: “Six decades of operations and excellence in providing high-quality medicines to the people who need them in Egypt is a significant legacy. Marking it today, is a testament of Viatris’ commitment and unwavering support to Egypt’s healthcare system. We continue to work closely with our partners in the public and private sectors as we develop sustainable and innovative solutions that improve patients’ health across Egypt and the region and their access to high-quality medicines.”

Mohamed Adel Sweilam, Country Manager Viatris Egypt, said: “Viatris aims to be a trusted partner, providing value across the healthcare value chain, to achieve Egypt healthcare vision 2030. This celebration is highly meaningful to Viatris’ team in Egypt as it reinforces our individual and collective passion to empower people worldwide to live healthier at every stage of life – something we have accomplished so far in our communities, and this remains a driving force for the future.”

In his keynote during the event, United States Chargé d’Affaires, a.i Ambassador Daniel Rubinstein said: “I applaud this 60-year partnership between the U.S. private sector and Egypt to manufacture pharmaceutical products, advance the health of Egyptians, and help achieve the goal of universal health coverage.”

Viatris Egypt has more than 400 employees in Egypt across its manufacturing and commercial operations. Viatris Egypt is at the forefront of major healthcare events in the country and has signed several public-private partnerships, memorandum of understanding, and collaborations with the Egyptian Drug Authority, the Cairo University faculty of Pharmacy established in 1827, and with professional medical entities.

In the community, Viatris is represented in the local association of Egypt manufacturers and the American Chamber of Commerce and has in its record several philanthropic initiatives. We seek to foster healthy communities by supporting education, health and disease awareness efforts that, in particular, promote empowering patients and creating access to care.

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories.

Viatris’ portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines and a variety of over-the-counter consumer products. With approximately 37,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter at @ViatrisInc, LinkedIn and YouTube.